← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
69 та иш
Иш: The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek +3
Шарҳ мақола20124 иқтибосABIDetection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Шарҳ мақола20203 иқтибосABIPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4
Шарҳ мақола20163 иқтибосABIUsing immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld +3
Шарҳ мақола20183 иқтибосABIL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
Kwangsoo Kim, Jae‐Ho Jeong, Daejin Lim +9
Мақола20152 иқтибосABIMitochondrial dysfunction and oxidative stress in heart disease
Jessica N. Peoples, Anita Saraf, Nasab Ghazal +2
Шарҳ мақола20192 иқтибосABIReactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1
Шарҳ мақола20202 иқтибосABIAnti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Jihane Boustani, Benoît Lecoester, Jérémy Baude +4
Шарҳ мақола20212 иқтибосABI